Fructose as a novel nutraceutical for acetaminophen (APAP)-induced hepatotoxicity

Abstract

Acetaminophen (APAP) is the most widely used analgesic in the world. APAP overdose can cause severe hepatotoxicity and therefore is the most common cause of drug-induced liver injury. The only approved treatment for APAP overdose is N-acetyl-cysteine (NAC) supplementation. However, the narrow efficacy window of the drug severely limits its clinical use, prompting the search for other therapeutic options to counteract APAP toxicity. Recent research has pointed to fructose as a novel nutraceutical for APAP-induced liver injury. This review summarizes the current understanding of the molecular mechanisms underlying APAP-induced liver injury, introduces how fructose supplementation could prevent and treat APAP liver toxicity with a focus on the ChREBPα-FGF21 pathway, and proposes possible future directions of study.

Keywords

Acetaminophen toxicity / fructose / ChREBPα / FGF21

References

[1] Ayoub SS.Paracetamol (acetaminophen): a familiar drug with an unexplained mechanism of action.Temperature2021;8:351-71 PMCID:PMC8654482

[2] Ghanem CI,Manautou JE.Acetaminophen from liver to brain: New insights into drug pharmacological action and toxicity.Pharmacol Res2016;109:119-31 PMCID:PMC4912877

[3] Esh CJ,Mauger AR.Pharmacological hypotheses: is acetaminophen selective in its cyclooxygenase inhibition?.Pharmacol Res Perspe2021;9:e00835 PMCID:PMC8287062

[4] Flower RJ.Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol).Nature1972;240:410-1.

[5] Saliba SW,Fortwängler E.AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity.J Neuroinflamm2017;14:246 PMCID:PMC5729401

[6] Bookout AL,Owen BM.FGF21 regulates metabolism and circadian behavior by acting on the nervous system.Nat Med2013;19:1147-52.

[7] Yoon E,Choudhary M,Pyrsopoulos N.Acetaminophen-induced hepatotoxicity: a comprehensive update.J Clin Transl Hepatol2016;4:131-42. PMCID:PMC4913076

[8] Blieden M,Shah D.A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States.Expert Rev Clin Pharmacol2014;7:341-8

[9] Lancaster EM,Zarrinpar A.Acetaminophen hepatotoxicity: an updated review.Arch Toxicol2015;89:193-9

[10] Chiew AL.Acetaminophen poisoning.Crit Care Clin2021;37:543-61

[11] Fisher ES.Chapter Ten-Evaluation and treatment of acetaminophen toxicity.Adv Pharmacol2019;85:263-72

[12] Saccomano SJ.Acute acetaminophen toxicity in adults.Nurse Pract2019;44:42-7.

[13] Chun LJ,Busuttil RW.Acetaminophen hepatotoxicity and acute liver failure.J Clin Gastroenterol2009;43:342-9

[14] Agrawal S.Acetaminophen toxicity. Treasure Island (FL): StatPearls Publishing; 2023.

[15] Jaeschke H.Cytochrome P450-derived versus mitochondrial oxidant stress in acetaminophen hepatotoxicity.Toxicol Lett2015;235:216-7 PMCID:PMC4536554

[16] Raffa RB,Taylor R Jr,Patrick JT.Acetaminophen (paracetamol) oral absorption and clinical influences.Pain Pract2014;14:668-77.

[17] Schäfer C,Höglinger O,Lornejad-Schäfer MR.Acetaminophen changes intestinal epithelial cell membrane properties, subsequently affecting absorption processes.Cell Physiol Biochem2013;32:431-47

[18] Southren DL,Haastrup AA,Chang MG.An examination of gastrointestinal absorption using the acetaminophen absorption test in critically ill patients with COVID-19: a retrospective cohort study.Nutr Clin Pract2021;36:853-62 PMCID:PMC8242470

[19] Marin TM,Rocco SA.Acetaminophen absorption and metabolism in an intestine/liver microphysiological system.Chem Biol Interact2019;299:59-76

[20] Zillen D,Kant G,Mian P.Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity.Clin Case Rep2021;9:e04611 PMCID:PMC8593780

[21] Ouzzine M,Ramalanjaona N,Fournel-Gigleux S.The UDP-glucuronosyltransferases of the blood-brain barrier: their role in drug metabolism and detoxication.Front Cell Neurosci2014;8:349 PMCID:PMC4211562

[22] Mazaleuskaya LL,Thorn CF,Altman RB.PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.Pharmacogenet Genom2015;25:416-26 PMCID:PMC4498995

[23] Zhao P.Effects of ethanol dose and ethanol withdrawal on rat liver mitochondrial glutathione: implication of potentiated acetaminophen toxicity in alcoholics.Drug Metab Dispos2002;30:1413-7

[24] Zaher H,Ward JM.Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice.Toxicol Appl Pharmacol1998;152:193-9.

[25] Ben-Shachar R,Luo S,Reed M.The biochemistry of acetaminophen hepatotoxicity and rescue: a mathematical model.Theor Biol Med Model2012;9:55 PMCID:PMC3576299

[26] Mitchell JR,Potter WZ,Brodie BB.Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione.J Pharmacol Exp Ther1973;187:211-7

[27] Leeming MG,Wille U,O'Hair RA.What are the potential sites of protein arylation by N-Acetyl-p-benzoquinone imine (NAPQI)?.Chem Res Toxicol2015;28:2224-33

[28] Du K,Jaeschke H.Oxidative stress during acetaminophen hepatotoxicity: sources, pathophysiological role and therapeutic potential.Redox Biol2016;10:148-56 PMCID:PMC5065645

[29] Licata A,Stankevičiūtė S.N-Acetylcysteine for preventing acetaminophen-induced liver injury: a comprehensive review.Front Pharmacol2022;13:828565 PMCID:PMC9399785

[30] Corcoran GB.Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-L-cysteine in vivo: studies with N-acetyl-D-cysteine in mice.J Pharmacol Exp Ther1986;238:54-61

[31] Lauterburg BH,Mitchell JR.Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo.J Clin Invest1983;71:980-91 PMCID:PMC436956

[32] Tobwala S,Fan W.Comparative evaluation of N-acetylcysteine and N-acetylcysteineamide in acetaminophen-induced hepatotoxicity in human hepatoma HepaRG cells.Exp Biol Med2015;240:261-72 PMCID:PMC4935326

[33] Saito C,Jaeschke H.Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine.Hepatology2010;51:246-54 PMCID:PMC2977522

[34] Bateman DN.Changing the management of paracetamol poisoning.Clin Ther2015;37:2135-41

[35] Peterson RG.Toxicity of acetaminophen overdose.JACEP1978;7:202-5

[36] Kerr F,Whyte IM.The australasian clinical toxicology investigators collaboration randomized trial of different loading infusion rates of N-acetylcysteine.Ann Emerg Med2005;45:402-8

[37] Yang R,He X,Fink MP.Prolonged treatment with N-acetylcystine delays liver recovery from acetaminophen hepatotoxicity.Crit Care2009;13:R55 PMCID:PMC2689502

[38] Pakravan N,Sharma S,Megson I.Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose.Clin Toxicol2008;46:697-702

[39] Dear JW.Fomepizole should not be used more liberally in paracetamol overdose.Br J Clin Pharmacol2023;89:599-601

[40] Link SL,Osmon S,Rumack BH.Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series.Clin Toxicol2022;60:472-7

[41] Morrison EE,Gallagher B.POP Trial InvestigatorsPrincipal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial).EBioMedicine2019;46:423-30 PMCID:PMC6710902

[42] Chen Z,Zhang X.ResNet18DNN: prediction approach of drug-induced liver injury by deep neural network with ResNet18.Brief Bioinform2022;23:bbab503

[43] Ghosh A,Remien CH.The role of alcohol consumption on acetaminophen induced liver injury: Implications from a mathematical model.J Theor Biol2021;519:110559

[44] Prescott LF.Paracetamol, alcohol and the liver.Br J Clin Pharmacol2000;49:291-301 PMCID:PMC2014937

[45] Riordan SM.Alcohol exposure and paracetamol-induced hepatotoxicity.Addict Biol2002;7:191-206

[46] Tsuchiya Y,Hirata A.Effects of food restriction on the expression of genes related to acetaminophen-induced liver toxicity in rats.J Toxicol Pathol2018;31:267-74 PMCID:PMC6206280

[47] Lee SS,Pineau T,Gonzalez FJ.Role of CYP2E1 in the hepatotoxicity of acetaminophen.J Biol Chem1996;271:12063-7

[48] O'Shea D,Kim RB.Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.Clin Pharmacol Ther1994;56:359-67

[49] Villeneuve JP,Bruneau J,Pomier-Layrargues G.Pharmacokinetics and metabolism of acetaminophen in normal, alcoholic and cirrhotic subjects.Gastroenterol Clin Biol1983;7:898-902

[50] Vos MB,Gillespie C,Blanck HM.Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey.Medscape J Med2008;10:160. [PMID:18769702 PMCID:PMC2525476]

[51] Ishida K,Sakai T.Effects of fructose-induced hypertriglyceridemia on hepatorenal toxicity of acetaminophen in rats.Exp Toxicol Pathol1995;47:509-16.

[52] Cho S,Chlipala G.Fructose diet alleviates acetaminophen-induced hepatotoxicity in mice.PLoS One2017;12:e0182977 PMCID:PMC5568217

[53] Zhang D,Ospina E.Fructose protects against acetaminophen-induced hepatotoxicity mainly by activating the carbohydrate-response element-binding protein α-fibroblast growth factor 21 axis in mice.Hepatol Commun2021;5:992-1008. PMCID:PMC8183176

[54] Ye D,Li H.Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice.Hepatology2014;60:977-89

[55] Lin X,Hu H.Metabolic role of fibroblast growth factor 21 in liver, adipose and nervous system tissues.Biomed Rep2017;6:495-502 PMCID:PMC5431415

[56] Ma L,Towle HC.Direct role of ChREBP.Mlx in regulating hepatic glucose-responsive genes.J Biol Chem2005;280:12019-27.

[57] Ortega-Prieto P.Carbohydrate sensing through the transcription factor ChREBP.Front Genet2019;10:472 PMCID:PMC6593282

[58] Dushay JR,Mitten EK,Herman MA.Fructose ingestion acutely stimulates circulating FGF21 levels in humans.Mol Metab2015;4:51-7. PMCID:PMC4314524

[59] Lee HJ.Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism.BMB Rep2018;51:429-36 PMCID:PMC6177502

[60] Zhang D,VanDommelen K.Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity.J Clin Invest2017;127:2855-67 PMCID:PMC5490767

[61] Minard AY,Yang P.mTORC1 is a major regulatory node in the FGF21 signaling network in adipocytes.Cell Rep2016;17:29-36 PMCID:PMC6485955

[62] Lu Q,Hao M.The mTOR promotes oxidative stress-induced apoptosis of mesangial cells in diabetic nephropathy.Mol Cell Endocrinol2018;473:31-43.

[63] Woo Y,Jung YM.mTOR-mediated antioxidant activation in solid tumor radioresistance.J Oncol2019;2019:5956867 PMCID:PMC6942807

[64] Kwon D,Correia MA.Cytochrome P450 endoplasmic reticulum-associated degradation (ERAD): therapeutic and pathophysiological implications.Acta Pharm Sin B2020;10:42-60 PMCID:PMC6976991

[65] Leise MD,Talwalkar JA.Drug-induced liver injury.Mayo Clin Proc2014;89:95-106